Brand Name: ELFABRIO. Generic Name: (pegunigalsidase alfa-iwxj). ELFABRIO (pegunigalsidase alfa-iwxj) is used to treat confirmed Fabry disease.
ELFABRIO is an enzyme replacement therapy that is used for the treatment of Fabry disease in adult patients. Fabry disease is an inherited disorder that occurs when the enzyme alpha-galactosidase-A is deficient, affecting the breakdown of a type of fat called globotriaosylceramide (Gb3) in various tissues of the body such as the kidney, heart, brain, nerves, and digestive system.
Brand Name: | ELFABRIO |
Generic Name: | pegunigalsidase alfa-iwxj |
Strength: | Injection: 20 mg/10 mL (2 mg/mL) solution in a single-dose vial. |
Manufacturer: | Chiesi USA, Inc. |
Approved By: | EMA, USFDA |
Source Details: Patient Information
IPN, New Delhi can facilitate patient to import of “ELFABRIO (pegunigalsidase alfa-iwxj)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for ELFABRIO (pegunigalsidase alfa-iwxj) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.